In humans, it has been demonstrated that NEP mRNA, protein, and activity levels are significantly reduced in high plaque areas, particularly the hippocampus and frontal cortex, in AD brains as compared to healthy controls [21], [22]. Here, MME is linked to Alzheimer disease.